Pharmacokinetics and pharmacodynamics of VEGF-neutralizing antibodies

BACKGROUND: Vascular endothelial growth factor (VEGF) is a potent regulator of angiogenesis, and its role in cancer biology has been widely studied. Many cancer therapies target angiogenesis, with a focus being on VEGF-mediated signaling such as antibodies to VEGF. However, it is difficult to predic...

Descripción completa

Detalles Bibliográficos
Autores principales: Finley, Stacey D, Engel-Stefanini, Marianne O, Imoukhuede, PI, Popel, Aleksander S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229549/
https://www.ncbi.nlm.nih.gov/pubmed/22104283
http://dx.doi.org/10.1186/1752-0509-5-193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229549/
https://www.ncbi.nlm.nih.gov/pubmed/22104283
http://dx.doi.org/10.1186/1752-0509-5-193

Ejemplares similares